Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pontus Lundberg

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 26, 2008
Antiprion properties of prion protein-derived cell-penetrating peptidesKajsa Löfgren, Anna Wahlström, Pontus Lundberg, et al.
Journal of Medicinal Chemistry|April 20, 2026
Discovery and Development of Voxvoganan: First-in-Class Synthetic Antimicrobial PeptidomimeticWenche Stensen, Dina Jurman, Jon Lind, et al.
Annals of Hematology|March 17, 2015
Erythropoietin receptor mutation--a rush of blood to the head?Andreas Holbro, Radek Skoda, Pontus Lundberg, et al.
Biochimica Et Biophysica Acta|October 31, 2007
Relevance of the N-terminal NLS-like sequence of the prion protein for membrane perturbation effectsKamila Oglecka, Pontus Lundberg, Mazin Magzoub, et al.
Polymer Chemistry|December 9, 2014
Physiologically relevant, pH-responsive PEG-based block and statistical copolymers with <i>N,N</i>-diisopropylamine unitsAnnabelle Lee, Pontus Lundberg, Daniel Klinger, et al.
Leukemia & Lymphoma|December 5, 2017
Clonogenic versus morphogenic mutations in myeloid neoplasms: chronologic observations in a U2AF1, TET2, CSF3R and JAK2 'co-mutated' myeloproliferative neoplasm suggest a hierarchical order of mutations and potential predictive value for kinase inhibitor treatment responseMagdalena M Gerlach, Pontus Lundberg, Joerg Halter, et al.
Blood|April 26, 2014
Somatic mutations in calreticulin can be found in pedigrees with familial predisposition to myeloproliferative neoplasmsPontus Lundberg, Ronny Nienhold, Achille Ambrosetti, et al.
ACS Applied Materials & Interfaces|April 2, 2010
Poly(ethylene glycol)-based thiol-ene hydrogel coatings-curing chemistry, aqueous stability, and potential marine antifouling applicationsPontus Lundberg, Anouk Bruin, Job W Klijnstra, et al.
The New England Journal of Medicine|March 8, 2018
A Gain-of-Function Mutation in EPO in Familial ErythrocytosisJakub Zmajkovic, Pontus Lundberg, Ronny Nienhold, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|November 6, 2018
RUNX1 Mutations Can Lead to Aberrant Expression of CD79a and PAX5 in Acute Myelogenous Leukemias: A Potential Diagnostic PitfallThomas Menter, Pontus Lundberg, Friedel Wenzel, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 26, 2008
Antiprion properties of prion protein-derived cell-penetrating peptidesKajsa Löfgren, Anna Wahlström, Pontus Lundberg, et al.
Journal of Medicinal Chemistry|April 20, 2026
Discovery and Development of Voxvoganan: First-in-Class Synthetic Antimicrobial PeptidomimeticWenche Stensen, Dina Jurman, Jon Lind, et al.
Annals of Hematology|March 17, 2015
Erythropoietin receptor mutation--a rush of blood to the head?Andreas Holbro, Radek Skoda, Pontus Lundberg, et al.
Biochimica Et Biophysica Acta|October 31, 2007
Relevance of the N-terminal NLS-like sequence of the prion protein for membrane perturbation effectsKamila Oglecka, Pontus Lundberg, Mazin Magzoub, et al.
Polymer Chemistry|December 9, 2014
Physiologically relevant, pH-responsive PEG-based block and statistical copolymers with <i>N,N</i>-diisopropylamine unitsAnnabelle Lee, Pontus Lundberg, Daniel Klinger, et al.
Leukemia & Lymphoma|December 5, 2017
Clonogenic versus morphogenic mutations in myeloid neoplasms: chronologic observations in a U2AF1, TET2, CSF3R and JAK2 'co-mutated' myeloproliferative neoplasm suggest a hierarchical order of mutations and potential predictive value for kinase inhibitor treatment responseMagdalena M Gerlach, Pontus Lundberg, Joerg Halter, et al.
Blood|April 26, 2014
Somatic mutations in calreticulin can be found in pedigrees with familial predisposition to myeloproliferative neoplasmsPontus Lundberg, Ronny Nienhold, Achille Ambrosetti, et al.
ACS Applied Materials & Interfaces|April 2, 2010
Poly(ethylene glycol)-based thiol-ene hydrogel coatings-curing chemistry, aqueous stability, and potential marine antifouling applicationsPontus Lundberg, Anouk Bruin, Job W Klijnstra, et al.
The New England Journal of Medicine|March 8, 2018
A Gain-of-Function Mutation in EPO in Familial ErythrocytosisJakub Zmajkovic, Pontus Lundberg, Ronny Nienhold, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|November 6, 2018
RUNX1 Mutations Can Lead to Aberrant Expression of CD79a and PAX5 in Acute Myelogenous Leukemias: A Potential Diagnostic PitfallThomas Menter, Pontus Lundberg, Friedel Wenzel, et al.
Pageof 6